Jason Spark

founding member @canalecomm; prez @NIRI San Diego; #biotech #agencylife #girldad

[Jason Spark @JasonSpark858]

most of my work is behind the scenes. sometimes easier said than done. #photobomb #inadvertent #cnbc https://t.co/UIlVPR6Em9

[Eric Topol @EricTopol]

Ugh. Honey, I (new Alzheimer drugs) shrunk the brain
https://t.co/2LpM15zPRz
@ScienceMagazine @jcouzin

[Silverback Therapeutics @silverbacktx]

Today, our CEO, Laura Shawver, Ph.D. (@lshawverO), will be participating in the @statnews #STATSummit 2021 panel entitled “Breaking Biotech’s Barriers” moderated by @sheridan_kate at 2:40 p.m. ET / 11:40 a.m. PT. Learn more and register here: https://t.co/PznbhRn55N

[Jason Spark @JasonSpark858]

“You know what the happiest animal on Earth is? It’s a goldfish. You know why? Got a 10-second memory. Be a goldfish”

[Jason Spark @JasonSpark858]

The launch of the new season just might push me into commuting to work again. #drivetime #podcast

[Malcolm Gladwell @Gladwell]

Just a little last-minute market research before the launch of the new season of Revisionist History.

[Jason Spark @JasonSpark858]

regardless of where you land on this topic, issues management and crisis comms teams are put to an epic test here.

[Max Gelman @MaxGelman]

Breaking News: A third member of the FDA's expert panel has resigned in the wake of the controversial Alzheimer's drug approval, calling it the "worst drug approval decision in recent U.S. history"
https://t.co/p2XCZqnHIN

[Jason Spark @JasonSpark858]

The last time I mistakenly took that call, I asked the caller for their name and SS# to prove they were legit. They so craftily said that they were my father. Click

[Meg Tirrell @megtirrell]

Man it's such a bummer when your phone rings after you've just sent an email to someone you really hope gets back to you, and you don't know the number so you hope it's them, and you pick up excitedly only to find it's a scammer saying your social security # has been compromised.

[Jason Spark @JasonSpark858]

Truth! 🙌

[Amber Tong @AmberTongPW]

@Sparkbury At least you can always be the Spark!

[Jason Spark @JasonSpark858]

I was the Spark first. But not sure I have a claim in this fight. @AmberTongPW

[Endpoints News @endpts]

Spark Therapeutics, which is now a subsidiary of Roche, has sued bluebird for trademark infringement — through a promotional campaign around its experimental treatment for sickle cell disease where the word “spark” features prominently.

https://t.co/OtwnPLNEpQ

[Jason Spark @JasonSpark858]

please don't dilute the Spark name. 😅@pharmalot

[STAT @statnews]

Spark Therapeutics claims that Bluebird Bio has “misappropriated and diluted” the Spark name. https://t.co/74VSdGUfhd

[Jason Spark @JasonSpark858]

"Boyz II Men(in): Pass You By" is a follow up to "Doin' Just Fine" and "The Exclusive Interview" Boyz II Men(in) reports also by Jonathan Chang @SVBLeerink

Never skipped a beat... 🤯

[Jason Spark @JasonSpark858]

Creative headlines today on the menin inhibitor news:
"Menin High Places" by @ORandyO @BioWorld
"Boyz II Men(in): Pass You By" by Jonathan Chang @SVBLeerink

Well played. 🎤💧

[Jason Spark @JasonSpark858]

Great use of digital, visual and written content to tell this story.

[Linsey Marr linseymarr.bsky.social @linseymarr]

Great visualization of how aerosols move through an airplane. Air changes out every 2-3 minutes and passes through a HEPA filter that removes aerosols. Very important to minimize mask-off time. https://t.co/CtODEYWCOk

[Jason Spark @JasonSpark858]

When do we think they’ll open up vaccinations to 55+? This group is in limbo.

[Eric Topol @EricTopol]

100 million shots in 100 days will be completed this week instead of April 30th (we're at 97 million administered; tomorrow is 50 days)
—Now 1 in 4 adults, 61% ≥ 65 year olds have had at least 1 dose
—At current 2.2M/d, would be >210 M shots in 100 days (+ hope we can rev up)

[Jason Spark @JasonSpark858]

LOL

[Dr. Paul Peter Tak @paulpetertak]

Really?

[Jason Spark @JasonSpark858]

Public companies need to be comfortable building and tapping into a deep tool chest of communications tactics to reach investors. This goes beyond retail. More than just PRs, conference calls and PowerPoints. #investorrelations #IR #communications @NIRI_National @WSJ

[WSJ CFO Journal @WSJCFO]

The recent surge of small investors into some companies’ stocks is pushing investor relations departments to seek ways of engaging with their new shareholders, @Nina_Trentmann reports for @CFOJournal @WSJ. https://t.co/B7tcIg7Yzc

[Jason Spark @JasonSpark858]

Moms cousin finally discharged after 30 days in ICU with Covid. Learning to walk and talk on his own again. That’s one strong hombre. 💪 Can’t #vaccinate fast enough.

[Jason Spark @JasonSpark858]

another great vaccine story from @helenbranswell. I often hear, I got "the moderna" but that's a perception concern as we move towards vaccinating a general population. https://t.co/ilKLLSWCgC via @statnews

[Ashish K. Jha @ashishkjha]

Agree with this

Right now, demand for vaccines >>> supply of vaccines

That will stay true for all of February and much of March

But by April, this will begin to change

And by May, supply > demand in US

By summer? supply >>> demand

[Jason Spark @JasonSpark858]

But my parents are not concerned with efficacy rates of various #covid vaccines. They want to know what will keep them out of the hospital, what will prevent severe infections and death. The good news is there are now several options that do that. 👍💪

[Jason Spark @JasonSpark858]

Family and friends continuously ask me to help filter the news to help make sense of it. I thought today’s @nytimes morning newsletter by @DLeonhardt was outstanding, and I shared it with as many as I could. He said what needed to be said.

https://t.co/ajMsQhWmf5

[Jason Spark @JasonSpark858]

The Pharma industry can be fixated on efficacy endpoints as it should. There is rigor behind science.